These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35457170)

  • 21. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
    Bjorklund NL; Sorg BA; Schenk JO
    Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW; Bailey SL
    Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats.
    Schwendt M; Reichel CM; See RE
    PLoS One; 2012; 7(3):e34299. PubMed ID: 22479593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of mitragynine on extracellular activity of brain dopamine and its metabolites.
    Yusoff NHM; Hassan Z; Murugaiyah V; Müller CP
    Brain Res Bull; 2022 Jan; 178():1-8. PubMed ID: 34774992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
    Wang X; Northcutt AL; Cochran TA; Zhang X; Fabisiak TJ; Haas ME; Amat J; Li H; Rice KC; Maier SF; Bachtell RK; Hutchinson MR; Watkins LR
    ACS Chem Neurosci; 2019 Aug; 10(8):3622-3634. PubMed ID: 31282647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
    Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
    Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended-access, but not limited-access, methamphetamine self-administration induces behavioral and nucleus accumbens dopamine response changes in rats.
    Le Cozannet R; Markou A; Kuczenski R
    Eur J Neurosci; 2013 Nov; 38(10):3487-95. PubMed ID: 24112125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of self-administered methamphetamine on GABAergic interneuron populations and functional connectivity of the nucleus accumbens and prefrontal cortex.
    Robinson KJ; Everett NA; Baracz SJ; Cornish JL
    Psychopharmacology (Berl); 2022 Sep; 239(9):2903-2919. PubMed ID: 35920922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.
    Fu K; Lin H; Miyamoto Y; Wu C; Yang J; Uno K; Nitta A
    Psychopharmacology (Berl); 2016 Mar; 233(5):831-40. PubMed ID: 26621348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
    Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
    Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemogenetic Inhibition of Dopamine D1-expressing Neurons in the Dorsal Striatum does not alter Methamphetamine Intake in either Male or Female Long Evans Rats.
    Job MO; Chojnacki MR; Daiwile AP; Cadet JL
    Neurosci Lett; 2020 Jun; 729():134987. PubMed ID: 32371155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
    Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.
    Krasnova IN; Justinova Z; Ladenheim B; Jayanthi S; McCoy MT; Barnes C; Warner JE; Goldberg SR; Cadet JL
    PLoS One; 2010 Jan; 5(1):e8790. PubMed ID: 20098750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
    Cass WA; Smith MP; Peters LE
    Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methamphetamine, morphine, and their combination: acute changes in striatal dopaminergic transmission evaluated by microdialysis in awake rats.
    Pereira FC; Lourenço E; Milhazes N; Morgadinho T; Ribeiro CF; Ali SF; Macedo TR
    Ann N Y Acad Sci; 2006 Aug; 1074():160-73. PubMed ID: 17105914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.
    Motbey CP; Clemens KJ; Apetz N; Winstock AR; Ramsey J; Li KM; Wyatt N; Callaghan PD; Bowen MT; Cornish JL; McGregor IS
    J Psychopharmacol; 2013 Sep; 27(9):823-36. PubMed ID: 23739178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
    Baracz SJ; Parker LM; Suraev AS; Everett NA; Goodchild AK; McGregor IS; Cornish JL
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26563756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
    Pei Y; Asif-Malik A; Hoener M; Canales JJ
    Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.